Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: There has been controversy about the role of Toll-like receptor 2 (TLR2) in renal injury following ureteric obstruction. Although inhibition of the renin angiotensin system (RAS) reduces TLR2 expression in mice, the exact relationship between TLR2 and RAS is not known. The aim of this study was to determine whether the RAS modulates TLR2. Methods: We used 8-week-old male wild type (WT) and TLR2-knockout (KO) mice on a C57Bl/6 background. Unilateral ureteral obstruction (UUO) was induced by complete ligation of the left ureter. Angiotensin (Ang) II (1,000 ng/kg/ min) and the direct renin inhibitor aliskiren (25 mg/kg/day) were administrated to mice using an osmotic minipump. Molecular and histologic evaluations were performed. Results: Ang II infusion increased mRNA expression of TLR2 in WT mouse kidneys (p < 0.05). The expression of renin mRNA in TLR2-KO UUO kidneys was significantly higher than that in WT UUO kidneys (p < 0.05). There were no differences in tissue injury score or mRNA expression of monocyte chemotactic protein 1 (MCP-1), osteopontin (OPN), or transforming growth factor β (TGF-β) between TLR2-KO UUO and WT UUO kidneys. However, aliskiren decreased the tissue injury score and mRNA expression of TLR2, MCP-1, OPN, and TGF-β in WT UUO kidneys (p < 0.05). Aliskiren-treated TLR2-KO UUO kidneys showed less kidney injury than aliskiren-treated WT UUO kidneys. Conclusions: TLR2 deletion induced activation of the RAS in UUO kidneys. Moreover, inhibition of both RAS and TLR2 had an additive ameliorative effect on UUO injury of the kidney.
Abstract
Background/Aims: There has been controversy about the role of Toll-like receptor 2 (TLR2) in renal injury following ureteric obstruction. Although inhibition of the renin angiotensin system (RAS) reduces TLR2 expression in mice, the exact relationship between TLR2 and RAS is not known. The aim of this study was to determine whether the RAS modulates TLR2. Methods: We used 8-week-old male wild type (WT) and TLR2-knockout (KO) mice on a C57Bl/6 background. Unilateral ureteral obstruction (UUO) was induced by complete ligation of the left ureter. Angiotensin (Ang) II (1,000 ng/kg/ min) and the direct renin inhibitor aliskiren (25 mg/kg/day) were administrated to mice using an osmotic minipump. Molecular and histologic evaluations were performed. Results: Ang II infusion increased mRNA expression of TLR2 in WT mouse kidneys (p < 0.05). The expression of renin mRNA in TLR2-KO UUO kidneys was significantly higher than that in WT UUO kidneys (p < 0.05). There were no differences in tissue injury score or mRNA expression of monocyte chemotactic protein 1 (MCP-1), osteopontin (OPN), or transforming growth factor β (TGF-β) between TLR2-KO UUO and WT UUO kidneys. However, aliskiren decreased the tissue injury score and mRNA expression of TLR2, MCP-1, OPN, and TGF-β in WT UUO kidneys (p < 0.05). Aliskiren-treated TLR2-KO UUO kidneys showed less kidney injury than aliskiren-treated WT UUO kidneys. Conclusions: TLR2 deletion induced activation of the RAS in UUO kidneys. Moreover, inhibition of both RAS and TLR2 had an additive ameliorative effect on UUO injury of the kidney.
참고문헌 (31)
- Taylor KR, "Hyaluronan fragments stimulate endothelial recognition of injury through TLR4", J Biol Chem, 279, pp.17079~17084 (2004)
- Saemann MD, "Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism", J Clin Invest, 115, pp.468~475 (2005)
- Schaefer L, "The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages", J Clin Invest, 115, pp.2223~2233 (2005)
- Scheibner KA, "Hyaluronan fragments act as an endogenous danger signal by engaging TLR2", J Immunol, 177, pp.1272~1281 (2006)
- Miyake K, "Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors", Semin Immunol, 19, pp.3~10 (2007)
- 민혜숙, "Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet", Kidney Research and Clinical Practice, 33(1), pp.33~44 (2014), 대한신장학회
- Leemans JC, "Renal-associated TLR2 mediates ischemia", reperfusion injury in the kidney, 2005, pp.115, 2894~2903
- Wu H, "TLR4 activation mediates kidney ischemia", reperfusion injury, 2007, pp.117, 2847~2859
- Pulskens WP, "Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia", reperfusion injury, 2008, pp.3, e3596~
- Leemans JC, "The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury", PLoS One, 4, pp.e5704~ (2009)
- Chowdhury P, "Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction", Nephron Exp Nephrol, 115, pp.e122~e130 (2010)
- Esteban V, "Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction", J Am Soc Nephrol, 15, pp.1514~1529 (2004)
- Chevalier RL, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy", Kidney Int, 75, pp.1145~1152 (2009)
- Choi DE, "Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice", J Urol, 186, pp.694~701 (2011)
- Kaneto H, "Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney", Kidney Int, 45, pp.1637~1647 (1994)
- Ahn KO, "Influence of angiotensin II on expression of Toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy", Transplantation, 83, pp.938~947 (2007)
- Johnson GB, "Evolutionary clues to the functions of the Toll-like family as surveillance receptors", Trends Immunol, 24, pp.19~24 (2003)
- Wu WP, "A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren", Am J Physiol Renal Physiol, 299, pp.F929~F941 (2010)
- Yoo KH, "Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction", Am J Physiol, 273(2 Pt 2), pp.R503~R509 (1997)
- Yoon HE, "Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy", Nephrol Dial Transplant, 26, pp.800~813 (2011)
- Amann B, "ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1", Diabetes Care, 26, pp.2421~2425 (2003)
- Wolak T, "Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney", Kidney Int, 76, pp.32~43 (2009)
- Persy VP, "Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice", Kidney Int, 63, pp.543~553 (2003)
- Huang Y, "Renin increases mesangial cell transforming growth factorbeta1and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms", Kidney Int, 69, pp.105~113 (2006)
- Burns WC, "Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7", MAS-1-dependent pathways, 2010, pp.299, F585~F593
- Wolf G, "Angiotensin II upregulates Toll-like receptor 4 on mesangial cells", J Am Soc Nephrol, 17, pp.1585~1593 (2006)
- Ji Y, "Angiotensin II induces inflammatory response partly via Toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells", Cell Physiol Biochem, 23, pp.265~276 (2009)
- Lim SW, "Cyclosporine-induced renal injury induces Toll-like receptor and maturation of dendritic cells", Transplantation, 80, pp.691~699 (2005)
- Rivera CA, "Toll-like receptor-2deficiency enhances non-alcoholic steatohepatitis", BMC Gastroenterol, 10, pp.52~ (2010)
- West XZ, "Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands", Nature, 467, pp.972~976 (2010)
- Shigeoka AA, "TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways", J Immunol, 178, pp.6252~6258 (2007)